Bioventus Inc expected to post earnings of 21 cents a share - Earnings Preview

Bioventus

04/08/2025 15:05

Bioventus Inc BVS.OQ BVS.O is expected to  show a fall in quarterly revenue when it reports  results on August 6 for the period ending June 30 2025

The Durham North Carolina-based  company is expected to report a 3.5% decrease in revenue to $145.863 million from $151.22 million a year ago, according to the mean estimate from 4 analysts, based on LSEG data.

​LSEG's mean analyst estimate for Bioventus Inc is for earnings of 21 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Bioventus Inc is $15.00, about 58.8% above its last closing price of $6.18

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2025
0.05
0.02
0.08
Beat
242.9
Dec. 31 2025
0.08
0.15
Beat
80
Sep. 30 2024
0.01
0.03
0.06
Beat
100​
Jun. 30 2024
0.07
0.07
0.19
Beat
185
​​Mar. 31 2024
-0.06
-0.07
0.07
Beat
193.3
Dec. 31 2023
0.05
0.02
0.07
Beat
250​
Sep. 30 2023
-0.02
-0.02
0.05
Beat
350
Jun. 30 2023
0.01
0.00
0.14
Beat


This summary was machine generated August 4 at 14:05 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)